These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3203686)

  • 1. Inhibition of uridine phosphorylase by pyrimidine nucleoside analogs and consideration of substrate binding to the enzyme based on solution conformation as seen by NMR spectroscopy.
    Veres Z; Neszmélyi A; Szabolcs A; Dénes G
    Eur J Biochem; 1988 Dec; 178(1):173-81. PubMed ID: 3203686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the 3'-OH group on the conformation and binding ability of anhydropyrimidine nucleosides to uridine phosphorylase.
    Veres Z; Neszmélyi A; Szabolcs A; Kiss AI; Dénes G
    Arch Biochem Biophys; 1991 Apr; 286(1):1-5. PubMed ID: 1897940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Substituted-2,2'-anhydrouridines, potent inhibitors of uridine phosphorylase.
    Veres Z; Szabolcs A; Szinai I; Dénes G; Kajtár-Peredy M; Otvös L
    Biochem Pharmacol; 1985 May; 34(10):1737-40. PubMed ID: 4004890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uridine phosphorylase from Hymenolepis diminuta (Cestoda): kinetics and inhibition by pyrimidine nucleoside analogs.
    Drabikowska AK
    Acta Biochim Pol; 1996; 43(4):733-41. PubMed ID: 9104511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of inhibitors of pyrimidine metabolism.
    Cha SM
    Yonsei Med J; 1989 Dec; 30(4):315-26. PubMed ID: 2697111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the N-glycosidic bond conformation and modifications in the pentose moiety on the binding of nucleoside ligands to uridine phosphorylase.
    el Kouni MH; Naguib FN; Chu SH; Cha SM; Ueda T; Gosselin G; Imbach JL; Shealy YF; Otter BA
    Mol Pharmacol; 1988 Aug; 34(2):104-10. PubMed ID: 3412318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship of ligands of the pyrimidine nucleoside phosphorylases.
    Niedzwicki JG; el Kouni MH; Chu SH; Cha S
    Biochem Pharmacol; 1983 Feb; 32(3):399-415. PubMed ID: 6847695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of uridine phosphorylase from Giardia lamblia by pyrimidine analogs.
    Jiménez BM; Kranz P; Lee CS; Gero AM; O'Sullivan WJ
    Biochem Pharmacol; 1989 Nov; 38(21):3785-9. PubMed ID: 2597172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrimidine acyclonucleosides, inhibitors of uridine phosphorylase.
    Niedzwicki JG; el Kouni MH; Chu SH; Cha S
    Biochem Pharmacol; 1981 Aug; 30(15):2097-101. PubMed ID: 7295329
    [No Abstract]   [Full Text] [Related]  

  • 10. Differential effects of 2,2'-anhydro-5-ethyluridine, a uridine phosphorylase inhibitor, on the antitumor activity of 5-fluorouridine and 5-fluoro-2'-deoxyuridine.
    Iigo M; Nishikata K; Nakajima Y; Szinai I; Veres Z; Szabolcs A; De Clercq E
    Biochem Pharmacol; 1990 Apr; 39(7):1247-53. PubMed ID: 2138895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyrimidine ribonucleoside phosphorylase activity vs 5- and/or 6-substituted uracil and uridine analogues, including conformational aspects.
    Krajewska E; Shugar D
    Biochem Pharmacol; 1982 Mar; 31(6):1097-102. PubMed ID: 7044382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitor properties of some 5-substituted uracil acyclonucleosides, and 2,2'-anhydrouridines versus uridine phosphorylase from E. coli and mammalian sources.
    Drabikowska AK; Lissowska L; Veres Z; Shugar D
    Biochem Pharmacol; 1987 Dec; 36(23):4125-8. PubMed ID: 3318842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclonucleoside analogues consisting of 5- and 5,6-substituted uracils and different acyclic chains: inhibitory properties vs purified E. coli uridine phosphorylase.
    Drabikowska AK; Lissowska L; Draminski M; Zgit-Wroblewska A; Shugar D
    Z Naturforsch C J Biosci; 1987 Mar; 42(3):288-96. PubMed ID: 2954322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrimidine homoribonucleosides: synthesis, solution conformation, and some biological properties.
    Lassota P; Kuśmierek JT; Stolarski R; Shugar D
    Z Naturforsch C J Biosci; 1987 May; 42(5):589-98. PubMed ID: 3037811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of modifications in the pentose moiety and conformational changes on the binding of nucleoside ligands to uridine phosphorylase from Toxoplasma gondii.
    el Kouni MH; Naguib FN; Panzica RP; Otter BA; Chu SH; Gosselin G; Chu CK; Schinazi RF; Shealy YF; Goudgaon N; Ozerov AA; Ueda T; Iltzsch MH
    Biochem Pharmacol; 1996 Jun; 51(12):1687-700. PubMed ID: 8687484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity of pyrimidine nucleoside phosphorylases and the phosphorolysis of 5-fluoro-2'-deoxyuridine.
    Woodman PW; Sarrif AM; Heidelberger C
    Cancer Res; 1980 Mar; 40(3):507-11. PubMed ID: 6451286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective syntheses of 6-substituted pyrimidine nucleosides and their interactions with uridine phosphorylase.
    Felczak K; Samulewicz I; Drabikowska AK; Kulikowski T; Shugar D
    Nucleic Acids Symp Ser; 1987; (18):65-8. PubMed ID: 3697153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase.
    Niedzwicki JG; Chu SH; el Kouni MH; Rowe EC; Cha S
    Biochem Pharmacol; 1982 May; 31(10):1857-61. PubMed ID: 7104017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of uridine phosphorylase from Escherichia coli by benzylacyclouridines.
    Park KS; el Kouni MH; Krenitsky TA; Chu SH; Cha S
    Biochem Pharmacol; 1986 Nov; 35(21):3853-5. PubMed ID: 3535805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nucleoside transport in murine lymphoma L5178Y cells and human erythrocytes by the uridine phosphorylase inhibitors 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine.
    Lee KH; el Kouni MH; Chu HS; Cha S
    Cancer Res; 1984 Sep; 44(9):3744-8. PubMed ID: 6744292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.